Natixis Neovasc Inc Transaction History

Natixis

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 24, 2023	BUY	$6.5 - $16.05 $323,557 - $798,936	49,778 New	49,778 $786,000

Ticker NVCN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 2,743,140
Description
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly kn...

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

Stay updated on Natixis with notifications on news.